NIFTY 24334.20 BANK 55087.15

Jagsonpal Pharmaceuticals Limited
Share Price Target & Analysis

NSE:JAGSNPHARM

228.53

VWAP

226

Open

227.46

Close

232.84

High

222.05

Low

328.04

52 Week High

224.96 ⇩
-2.50 (-1.1%)

JAGSNPHARM

(PHARMA)
52.7% Momentum

Turnaround Potential

110

52 Week Low

7.88

EPS

46.53

PE

7.58

PB

Economical
Quality

Gold
Valuation

#Analysis

NSE: JAGSNPHARM Share Price Financial Analysis & Valuation

Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals vertical. It is one of Micro Cap company with Market Capitalization of Rs 423.1 (in Cr). Total number of free float shares are 2.6 (in Lacs). Jagsonpal Pharmaceuticals Limited is listed on NSE with Exchange ID - INE048B01035 and trading code is NSE:JAGSNPHARM with short name JagsonpalPharma.

In the past 1 year, Jagsonpal Pharmaceuticals Limited has declared an equity dividend of Rs 4 per share. At the current share price of JAGSNPHARM at Rs 224.96, this results in a dividend yield of 1.78 %.

As per the Fundamental Analysis of NSE:JAGSNPHARM, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine JAGSNPHARM underlying value and future prospects. All of this data is available in JAGSNPHARM financial statements.

Quality of the Stock: As per the fundamental analysis of NSE:JAGSNPHARM, it is clearly understood that JAGSNPHARM is Economical performer in terms of earnings and profit margins with an EPS of 7.88. NSE:JAGSNPHARM book value per share as of today is 29.67. The current price to book ratio for JAGSNPHARM as of May 01, 2025 is 7.58.

Valuation of the Stock: The current valuation of JAGSNPHARM stock is like Gold which means currently the stock is Overpriced. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of JAGSNPHARM whether to BUY this stock at current valuation. The delivery percentage of JAGSNPHARM is 39.51% is very crucial parameter which shows that 39.51% investors are anticipating that the price of JAGSNPHARM share should go up with VWAP at 228.53.

Now, the main question is whether to BUY or SELL, NSE:JAGSNPHARM at current valuation.
As per latest Analysis No. #745:-

⇑ STRONG BUY JAGSNPHARM if All Greens

⇗ BUY JAGSNPHARM (at Lower Levels) if any 2 Greens

⇒ NEUTRAL or HOLD JAGSNPHARM (With Stop Loss) if only 1 Green

⇘ SELL JAGSNPHARM if NO Green Indicator

NSE: JAGSNPHARM Share Price Today (May 01, 2025)

(Jagsonpal Pharmaceuticals Limited Daily Analysis on the basis of JAGSNPHARM Intraday Graph & Trend)

Jagsonpal Pharmaceuticals Limited share price moved Down by -1.1% from its previous close of Rs 227.46. JAGSNPHARM stock last traded price is 224.96. JAGSNPHARM share price trend is Down with a total of 153359 stocks traded till now. It has touched an intraday high of Rs 232.84 and an intraday low of Rs 222.05. The JAGSNPHARM trading at 224.96, Down by Rs. -2.50, or -1.1 percent which suggests that most of the Traders are anticipating that the price of JAGSNPHARM share should go Down.

NSE: JAGSNPHARM Share Price Tomorrow Prediction

(Jagsonpal Pharmaceuticals Limited Share Price Prediction for Tomorrow & future forecast is based on Current Trend of JAGSNPHARM)

Jagsonpal Pharmaceuticals Limited share price moved Down by -1.1%. JAGSNPHARM share price short term trend is Down. It suggests that JAGSNPHARM Share Price for Tomorrow remains the same with VWAP at 228.53 will be treated as stop loss for intraday traders. Jagsonpal Pharmaceuticals Limited Long term investors can follow the JAGSNPHARM long term trend as mentiond in future forecast table.

NSE Code

NSE: JAGSNPHARM

JAGSNPHARM Share Price Today

 224.96

JAGSNPHARM Share Price Target Prediction for 2025 ^

 211.1 - 329.7

JAGSNPHARM Share Price Target Prediction for 2026*^

 329.7 - 351.2

JAGSNPHARM Share Price Target Prediction for 2027*^

 351.2 - 375.8

JAGSNPHARM Share Price Target Prediction for 2028*^

 395

JAGSNPHARM Share Price Target Prediction for 2029*^

 406

JAGSNPHARM Share Price Target Prediction for 2030*^

 442
JAGSNPHARM Current Book Value 2024
29.5

*Jagsonpal Pharmaceuticals Limited Short Term & Long Term share price target is based on current financial year earings of the company.
^JAGSNPHARM share price target prediction for 2025 2026 2027 to 2030 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.

JAGSNPHARM Technical Analysis

Candlestick Pattern: @214.25

JAGSNPHARM Moving Averages

BUY (2) NEUTRAL (0) SELL (12)
MA Simple Action S1 Expo Action E2
MA_5 216.3 SELL 218.24 SELL
MA_12 231.15 SELL 226.39 SELL
MA_20 238.01 SELL 230.41 SELL
MA_32 232.02 SELL 234.6 SELL
MA_50 240.6 SELL 235.65 SELL
MA_100 240.86 SELL 229.06 SELL
MA_200 190.64 BUY 203.66 BUY

JAGSNPHARM Trend Oscillators

BUY (0) NEUTRAL (1) SELL (3)
Trend Oscillators Value Action
Bollinger Bands 238.01 Downtrend
MACD -2.93 SELL
ADX 18.92 NO or Weak Trend
DMI (+/-) 13.68 / 23.24 Downtrend

JAGSNPHARM Momentum Oscillators

BUY (1) NEUTRAL (7) SELL (4)
Momentum Oscillators Value Action
RSI 42.25 Neutral
STOCHASTIC_K (Fast) 37.97 Neutral
STOCHASTIC_D (Slow) 38.34 Neutral
CCI -89.54 Neutral
PSAR 255.01 SELL
TRUE RANGE 9.61 SELL
ATR 20.24 Neutral
WILLIAMS R -91.4 Oversold
TRIX 0 Neutral
STOCHASTIC RSI K 18.94 Oversold
STOCHASTIC RSI D 52.89 Neutral
MOMENTUM 0.95 BUY

JAGSNPHARM Last 1 Year Trend

Duration Value
1 Year 71.73%
3 Months -20.18%
1 Month 0.45%
1 Week -2.95%

JAGSNPHARM Technical Analysis Summary

Updated on 2025-02-24
Action Overall (%)
BUY 10%
NEUTRAL / HOLD 27%
SELL 63%

Most popular Questions & Answers about JAGSNPHARM


Jagsonpal Pharmaceuticals Limited stock last traded price is 224.96. JAGSNPHARM share price moved Down by -1.1% from its previous close of Rs 227.46.

Jagsonpal Pharmaceuticals Limited share price trend is Down with a total of 153359 stocks traded till now. It has touched an intraday high of Rs 331.3204 and an intraday low of Rs 222.05. The JAGSNPHARM trading at 224.96, Down by Rs. -2.50, or -1.1 percent which suggests that most of the Traders are anticipating that the price of JAGSNPHARM share should go Down and the Stop Loss will be around 228.53.

The market cap of Jagsonpal Pharmaceuticals Limited is ₹423.1 (in Cr) as of Apr 30, 2025.

The current price to earning ratio for Jagsonpal Pharmaceuticals Limited as of Apr 30, 2025 is 46.53.

The current price to book ratio for Jagsonpal Pharmaceuticals Limited as of Apr 30, 2025 is 7.58.

The highest price of Jagsonpal Pharmaceuticals Limited stock is ₹328.04 in the last 52-week.

The lowest price of Jagsonpal Pharmaceuticals Limited stock is ₹110 in the last 52-week.

Jagsonpal Pharmaceuticals Limited share trading at ₹224.96, Down by Rs. -2.50, or -1.1 percent which suggests that most of the traders are anticipating that the price of JAGSNPHARM share should go Down.

In 2023, Stock price target for Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) are ₹211.1 on downside and ₹329.7 on upside. Jagsonpal Pharmaceuticals Limited share price target is based on current financial year earings of the company.

In 2024, Stock price target for Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) are ₹329.7 on downside and ₹351.2 on upside. Jagsonpal Pharmaceuticals Limited share price target is based on forecasted future earnings of the company.

In 2025, Stock price target for Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) are ₹351.2 on downside and ₹375.8 on upside. Jagsonpal Pharmaceuticals Limited share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.

In next five years, Stock price target for Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) will be around ₹406 Jagsonpal Pharmaceuticals Limited share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of JAGSNPHARM.

The price of Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) shares moved by -1.1%. The short-term trend for JAGSNPHARM share price is Down. It implies that the share price of JAGSNPHARM will stay the same tomorrow and that intraday traders should treat VWAP at 228.53 as a stop loss. Investors with a long-term outlook can track JAGSNPHARM long-term trajectory, which is indicated in the future forecast table.

Estimated DCF Value of JAGSNPHARM stock is 94.5. Compared to the current market price of 224.96 INR, the JAGSNPHARM stock is Overvalued by 58%.

As per the fundamental analysis of Jagsonpal Pharmaceuticals Limited (JAGSNPHARM), it is of Economical quality in terms of earnings and profit margins with an EPS of 7.88. Jagsonpal Pharmaceuticals Limited book value per share as of today is 29.67. The current price to book ratio for JAGSNPHARM as of May 01, 2025 is 7.58.


NSE:JAGSNPHARM News & Other Useful Information about JAGSNPHARM Share Price


Peer Comparison of NSE: JAGSNPHARM

The Peers list includes companies operating in the same industry and having comparable market cap.

Sector: Pharmaceuticals

Company Price EPS BV
SUNPHARMA 1832.30 13.13 98.33
DIVISLAB 6087.00 78.09 513.62
MEDICAMEQ 426.85 7.48 163.16
CIPLA 1550.10 58.33 360.73
DRREDDY 1183.90 62.12 322.46
PGHH 15925.70 189.8 324.25
TORNTPHARM 3322.00 53.89 222.38
BIOCON 321.80 5.01 90.7
LUPIN 2095.60 67.15 481.38
ALKEM 5116.00 194.78 984.46
Updated at: 30 Apr 2025 15:59

Feel free to contact us, in case of any queries.

SITEMAP 4820
Disclaimer: Published information or data available on the Website may not be current or up to date and also any information or data available on this website may contain inaccuracies and/or typographical errors. Kindly refer any reliable source for its accuracy. If you select any of these stocks for your trades, you do so at your own risk.

Stocks to Watch Today

ADANIENT 2301.30 -29.30 (-1.26%) | ADANIGREEN 900.70 -21.70 (-2.35%) | ADANIPORTS 1216.50 0.10 (0.01%) | ADANITRANS 1010.05 -18.55 (-1.8%) | AMBUJACEM 539.70 5.75 (1.08%) | APOLLOHOSP 6977.00 -15.50 (-0.22%) | ASIANPAINT 2425.70 -25.40 (-1.04%) | ATGL 600.20 -9.55 (-1.57%) | AUROPHARMA 1229.10 19.50 (1.61%) | AXISBANK 1185.00 -2.30 (-0.19%) | BAJAJ-AUTO 8030.00 -48.50 (-0.6%) | BAJAJFINSV 1951.60 -115.30 (-5.58%) | BAJFINANCE 8634.50 -458.50 (-5.04%) | BALKRISIND 2675.10 77.40 (2.98%) | BANDHANBNK 165.62 -2.28 (-1.36%) | BANKBARODA 249.93 -3.29 (-1.3%) | BEL 314.10 -3.00 (-0.95%) | BERGEPAINT 544.20 -1.75 (-0.32%) | BHARTIARTL 1864.50 40.70 (2.23%) | BIOCON 321.80 2.95 (0.93%) | BOSCHLTD 29455.00 290.00 (0.99%) | BPCL 310.05 -1.65 (-0.53%) | BRITANNIA 5438.90 -29.40 (-0.54%) | CADILAHC 1100.00 -15.15 (-1.36%) | CIPLA 1550.10 8.60 (0.56%) | COALINDIA 385.30 -3.80 (-0.98%) | COLPAL 2587.40 -56.80 (-2.15%) | DABUR 487.75 4.10 (0.85%) | DIVISLAB 6087.00 -21.00 (-0.34%) | DLF 674.30 15.45 (2.34%) | DMART 4199.90 -110.10 (-2.55%) | DRREDDY 1183.90 7.90 (0.67%) | EICHERMOT 5567.00 -12.00 (-0.22%) | GAIL 189.09 -0.51 (-0.27%) | GLAND 1400.00 -12.90 (-0.91%) | GODREJCP 1260.50 -2.20 (-0.17%) | GRASIM 2737.50 -8.20 (-0.3%) | GUJGASLTD 453.50 -14.95 (-3.19%) | HAVELLS 1601.00 -21.80 (-1.34%) | HCLTECH 1567.50 -1.50 (-0.1%) | HDFC 2724.30 0.00 (0%) | HDFCAMC 4374.40 -41.60 (-0.94%) | HDFCBANK 1925.00 16.20 (0.85%) | HDFCLIFE 743.70 28.65 (4.01%) | HEROMOTOCO 3827.40 -25.30 (-0.66%) | HINDALCO 624.65 2.10 (0.34%) | HINDUNILVR 2342.10 20.40 (0.88%) | HINDZINC 439.20 -6.25 (-1.4%) | ICICIBANK 1427.00 -2.80 (-0.2%) | ICICIGI 1876.50 20.40 (1.1%) | ICICIPRULI 614.35 9.10 (1.5%) | INDIGO 5249.50 -14.50 (-0.28%) | INDUSINDBK 838.40 1.45 (0.17%) | INDUSTOWER 408.20 5.60 (1.39%) | INFY 1500.10 2.60 (0.17%) | IOB 37.53 -0.81 (-2.11%) | IOC 137.86 2.08 (1.53%) | ITC 425.80 -0.20 (-0.05%) | JSWSTEEL 1029.80 -5.80 (-0.56%) | KOTAKBANK 2208.10 3.10 (0.14%) | LT 3341.00 18.70 (0.56%) | LTI 6149.30 78.10 (1.29%) | LUPIN 2095.60 28.50 (1.38%) | M&M 2928.80 19.20 (0.66%) | MARICO 710.45 -0.90 (-0.13%) | MARUTI 12257.00 416.00 (3.51%) | MCDOWELL-N 1485.00 -14.35 (-0.96%) | MOTHERSUMI 187.83 -5.36 (-2.77%) | MUTHOOTFIN 2169.90 17.60 (0.82%) | NAUKRI 7069.50 10.50 (0.15%) | NESTLEIND 2388.20 0.70 (0.03%) | NMDC 64.79 -0.78 (-1.19%) | NTPC 354.55 -2.40 (-0.67%) | ONGC 244.45 -1.23 (-0.5%) | PEL 967.95 -20.70 (-2.09%) | PIDILITIND 3033.90 28.90 (0.96%) | PIIND 3640.20 -7.50 (-0.21%) | PNB 100.21 -2.42 (-2.36%) | POWERGRID 307.45 4.50 (1.49%) | RELIANCE 1405.00 5.30 (0.38%) | SAIL 113.71 -1.57 (-1.36%) | SBICARD 873.55 -4.85 (-0.55%) | SBILIFE 1765.80 35.70 (2.06%) | SBIN 788.65 -23.90 (-2.94%) | SHREECEM 29710.00 -315.00 (-1.05%) | SIEMENS 2901.50 -28.50 (-0.97%) | SRF 3008.90 -11.60 (-0.38%) | SUNPHARMA 1832.30 26.80 (1.48%) | TATACONSUM 1165.80 -3.10 (-0.27%) | TATAMOTORS 644.25 -21.35 (-3.21%) | TATAMTRDVR 768.65 33.35 (4.54%) | TATASTEEL 140.08 -1.42 (-1%) | TCS 3453.70 -18.80 (-0.54%) | TECHM 1503.00 7.70 (0.51%) | TITAN 3379.70 1.10 (0.03%) | TORNTPHARM 3322.00 -0.70 (-0.02%) | ULTRACEMCO 11641.00 -228.00 (-1.92%) | UPL 669.90 0.30 (0.04%) | VEDL 419.20 2.90 (0.7%) | WIPRO 241.50 0.10 (0.04%) |